Aurora Cannabis Q3 EPS Forecast Reduced by Atb Cap Markets

Aurora Cannabis Inc. (TSE:ACB) – Equities research analysts at Atb Cap Markets lowered their Q3 2025 earnings estimates for shares of Aurora Cannabis in a research report issued to clients and investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of ($0.18) per share for the quarter, down from their prior forecast of ($0.13). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.14) EPS, FY2025 earnings at ($0.14) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.02) EPS and FY2029 earnings at $0.56 EPS.

A number of other brokerages have also weighed in on ACB. ATB Capital decreased their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Aurora Cannabis currently has a consensus rating of “Moderate Buy” and an average target price of C$5.85.

Aurora Cannabis Stock Up 4.6 %

ACB stock opened at C$6.15 on Thursday. The stock has a market capitalization of C$336.16 million, a P/E ratio of -9.76 and a beta of 2.71. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. Aurora Cannabis has a 1-year low of C$3.84 and a 1-year high of C$12.85. The business has a fifty day moving average price of C$6.84 and a 200-day moving average price of C$7.53.

Insider Activity at Aurora Cannabis

In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of Aurora Cannabis stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.